$2.47T
Total marketcap
$85.22B
Total volume
BTC 50.53%     ETH 14.98%
Dominance

Melodiol Global Health COPHF Stock

0.0039 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
4.58M USD
LOW - HIGH [24H]
0.0039 - 0.0039 USD
VOLUME [24H]
50 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.1 USD

Melodiol Global Health Price Chart

Melodiol Global Health COPHF Financial and Trading Overview

Melodiol Global Health stock price 0.0039 USD
Previous Close 0.0099 USD
Open 0.01 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.01 - 0.01 USD
52 Week Range 0.0012 - 0.1 USD
Volume 10K USD
Avg. Volume 972.2K USD
Market Cap 25.67M USD
Beta (5Y Monthly) 2.597701
PE Ratio (TTM) N/A
EPS (TTM) -0.1 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

COPHF Valuation Measures

Enterprise Value 26.43M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.8788404
Price/Book (mrq) 0.8333333
Enterprise Value/Revenue 2.964
Enterprise Value/EBITDA -1.577

Trading Information

Melodiol Global Health Stock Price History

Beta (5Y Monthly) 2.597701
52-Week Change -68.94%
S&P500 52-Week Change 20.43%
52 Week High 0.1 USD
52 Week Low 0.0012 USD
50-Day Moving Average 0.01 USD
200-Day Moving Average 0.01 USD

COPHF Share Statistics

Avg. Volume (3 month) 972.2K USD
Avg. Daily Volume (10-Days) 2.41M USD
Shares Outstanding 2.57B
Float 1.53B
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -216.90%
Gross Margin 1.22%
EBITDA Margin -188.0020%

Management Effectiveness

Return on Assets (ttm) -35.93%
Return on Equity (ttm) -130.98%

Income Statement

Revenue (ttm) 8.92M USD
Revenue Per Share (ttm) 0.006 USD
Quarterly Revenue Growth (yoy) 43.60%
Gross Profit (ttm) 219K USD
EBITDA -16766000 USD
Net Income Avi to Common (ttm) -32782000 USD
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.39M USD
Total Cash Per Share (mrq) 0.001 USD
Total Debt (mrq) 6.67M USD
Total Debt/Equity (mrq) 29.92 USD
Current Ratio (mrq) 0.757
Book Value Per Share (mrq) 0.012

Cash Flow Statement

Operating Cash Flow (ttm) -17306000 USD
Levered Free Cash Flow (ttm) -6851000 USD

Profile of Melodiol Global Health

Country United States
State WA
City Nedlands
Address 145 Stirling Highway
ZIP 6009
Phone 61 8 9389 3180
Website https://melodiolglobalhealth.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Q&A For Melodiol Global Health Stock

What is a current COPHF stock price?

Melodiol Global Health COPHF stock price today per share is 0.0039 USD.

How to purchase Melodiol Global Health stock?

You can buy COPHF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Melodiol Global Health?

The stock symbol or ticker of Melodiol Global Health is COPHF.

Which industry does the Melodiol Global Health company belong to?

The Melodiol Global Health industry is Drug Manufacturers-Specialty & Generic.

How many shares does Melodiol Global Health have in circulation?

The max supply of Melodiol Global Health shares is 1.17B.

What is Melodiol Global Health Price to Earnings Ratio (PE Ratio)?

Melodiol Global Health PE Ratio is now.

What was Melodiol Global Health earnings per share over the trailing 12 months (TTM)?

Melodiol Global Health EPS is -0.1 USD over the trailing 12 months.

Which sector does the Melodiol Global Health company belong to?

The Melodiol Global Health sector is Healthcare.